Mynster Kronborg, Thit https://orcid.org/0000-0001-6344-8564
Webel, Henry https://orcid.org/0000-0001-8833-7617
O’Connell, Malene Barfod https://orcid.org/0000-0001-7226-8821
Danielsen, Karen Vagner https://orcid.org/0000-0001-7194-4541
Hobolth, Lise https://orcid.org/0000-0002-7607-3551
Møller, Søren https://orcid.org/0000-0001-9684-7764
Jensen, Rasmus Tanderup https://orcid.org/0000-0002-4241-3394
Bendtsen, Flemming https://orcid.org/0000-0002-8419-2104
Hansen, Torben https://orcid.org/0000-0001-8748-3831
Rasmussen, Simon https://orcid.org/0000-0001-6323-9041
Juel, Helene Bæk https://orcid.org/0000-0002-5763-8545
Kimer, Nina https://orcid.org/0000-0002-4807-1575
Clinical trials referenced in this document:
Documents that mention this clinical trial
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study
https://doi.org/10.1038/s41598-023-47384-2
Documents that mention this clinical trial
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study
https://doi.org/10.1038/s41598-023-47384-2
Funding for this research was provided by:
Novo Nordisk Fonden (NNF19SA0035440)
Novo Nordisk Fonden (NNF18CC0034900)
Beckett-Fonden (20-2-6102)
Novo Nordisk Foundation Center for Basic Metabolic Research (SABridge.ku.dk)
Article History
Received: 5 June 2023
Accepted: 13 November 2023
First Online: 16 November 2023
Competing interests
: The authors declare no competing interests.